会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明授权
    • (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
    • (噻吩-2-基) - 哌啶或四氢吡啶氮杂双环羧酰胺
    • US5610164A
    • 1997-03-11
    • US685132
    • 1996-07-24
    • Reinhardt B. BaudyJames A. NelsonMira A. Kanzelberger
    • Reinhardt B. BaudyJames A. NelsonMira A. Kanzelberger
    • C07D451/02A61K31/435
    • C07D451/02
    • This invention provides compounds having the structure ##STR1## wherein R is hydrogen, alkyl, alkenyl, alkynyl, --COR.sup.2, phenyl, or phenylalkyl; the dotted line represents an optional double bond;R.sup.1 is hydrogen, --OH, OR.sup.3, or is absent if the optional double bond is present;R.sup.2 and R.sup.3 are each, independently, alkyl, alkenyl, alkynyl, phenyl, or phenylalkyl;R.sup.4 is hydrogen, --OR.sup.5, alkyl, alkenyl, alkynyl, --COR.sup.5, --CO.sub.2 R.sup.5, --CONR.sup.5 R.sup.6, perhaloalkyl, halogen, phenyl, or phenylalkyl;R.sup.5 and R.sup.6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, phenyl, or phenylalkyl; andn=0-2or a pharmaceutically acceptable salt thereof that are useful as antipsychotic, antidepressant and anxiolytic agents useful in the treatment and relief of the symptoms of these disease states.
    • 本发明提供了具有结构“IMAGE”的化合物,其中R是氢,烷基,烯基,炔基,-COR 2,苯基或苯基烷基; 虚线表示可选的双键; R1是氢,-OH,OR3,如果存在任选的双键,则不存在; R2和R3各自独立地为烷基,烯基,炔基,苯基或苯基烷基; R 4是氢,-OR 5,烷基,烯基,炔基,-COR 5,-CO 2 R 5,-CONR 5 R 6,全卤代烷基,卤素,苯基或苯基烷基; R 5和R 6各自独立地为氢,烷基,烯基,炔基,苯基或苯基烷基; 和n = 0-2或其药学上可接受的盐,其可用作抗精神病药,抗抑郁药和抗焦虑剂,其用于治疗和缓解这些疾病状态。
    • 34. 发明授权
    • N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative
modification of low density lipoprotein
    • N-羟基脲作为5-脂氧合酶抑制剂和低密度脂蛋白的氧化修饰抑制剂
    • US5459154A
    • 1995-10-17
    • US148603
    • 1993-11-08
    • Michael S. MalamasJames A. Nelson
    • Michael S. MalamasJames A. Nelson
    • C07D263/32C07D277/24C07D277/30A61K31/42A61K31/425
    • C07D263/32C07D277/24
    • This invention relates to compounds having 5-lipoxygenase inhibiting properties and inhibition of oxidative modification of low density lipoprotein which have the formula: ##STR1## wherein: R.sup.1 and R.sup.3 are independently hydrogen, halogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, trifluoromethyl, or C.sub.1 -C.sub.6 trifluoroalkoxy;R.sub.2 is hydrogen or methyl;R.sup.4 is hydrogen, methyl or hydroxy;R.sup.5 is hydrogen, --NH.sub.2, C.sub.1 -C.sub.6 alkyl, aryl, aralkyl, or --N.dbd.C(CH.sub.3).sub.2 ;X and Y are independently O or S;and n is 0 or 1; or a pharmaceutically acceptable salt thereof.Compounds which inhibit 5-lipoxygenase are useful in the treatment of diseases mediated by leukotrienes such as inflammation or bronchoconstriction. Compounds which inhibit oxidative metabolism of low density lipoprotein are useful in the inhibition of atherosclerotic plaque formation.
    • 本发明涉及具有5-脂氧合酶抑制性质和抑制低密度脂蛋白氧化修饰的化合物,其具有下式:其中:R1和R3独立地是氢,卤素,C1-C6烷基,C1-C6烷氧基,三氟甲基 ,或C 1 -C 6三氟烷氧基; R2是氢或甲基; R4是氢,甲基或羟基; R5是氢,-NH2,C1-C6烷基,芳基,芳烷基或-N = C(CH3)2; X和Y独立地为O或S; 并且n为0或1; 或其药学上可接受的盐。 抑制5-脂氧合酶的化合物可用于治疗由白细胞三烯介导的疾病,例如炎症或支气管收缩。 抑制低密度脂蛋白氧化代谢的化合物可用于抑制动脉粥样硬化斑块形成。
    • 36. 发明授权
    • Apparatus and method for cross sectional imaging of a body
    • 用于身体横截面成像的装置和方法
    • US4577222A
    • 1986-03-18
    • US444613
    • 1982-11-26
    • Robert A. KrugerJames A. Nelson
    • Robert A. KrugerJames A. Nelson
    • A61B6/00A61B6/02G06T11/00H04N5/32
    • A61B6/481A61B6/02A61B6/504G06T11/005
    • The disclosure is directed to a method and apparatus for generating a processed image of a cross-section through a body. Fluoroscopic tomography is achieved wherein a series of video frames of a cross-section of a body can be viewed in real time. In this manner, for example, one can monitor the progress of a bolus of contrast material moving through a blood vessel in the cross-section being viewed. In a form of the disclosure, a recorded series of frames of a principal plane of a body being imaged can be processed to obtain a corresponding series of frames that represent a plane of interest that is spaced from the principal plane, thereby avoiding the necessity of re-exposure for each new plane to be viewed. In accordance with the disclosed method, a body is disposed between a combination of a source of radiation and an associated detector, such that a beam of radiation from the source impinges angularly on the body and passes through to the detector. Relative rotational motion is effected between the beam and the body, such that a principal plane of interest in the body remains substantially in focus during the relative rotational motion. A series of frames of electronic video signals are derived from the detector, at different rotational positions, the frames representing images of the radiation transmission characteristics of the body at a series of successive times. The series of frames are temporally filtered and then displayed. In a preferred embodiment, the temporal filtering step comprises filtering the series of frames of video signals with a filter function having a temporal frequency response that corresponds substantially the temporal frequency of the movement of a bolus of contrast material through the region being imaged.
    • 本公开涉及一种用于通过身体产生横截面的经处理图像的方法和装置。 实现了透视断层摄影,其中可以实时观看身体横截面的一系列视频帧。 以这种方式,例如,可以监视在所观察的横截面中移动通过血管的大量造影剂的进展。 以本公开的形式,可以处理正在成像的身体的主平面的记录的一系列帧,以获得表示与主平面间隔开的感兴趣平面的相应系列的帧,从而避免必要 每次新飞机重新曝光要被观看。 根据所公开的方法,身体设置在辐射源和相关联的检测器的组合之间,使得来自源的辐射束成角度地撞击在身体上并且通过到检测器。 在梁和本体之间进行相对旋转运动,使得在相对旋转运动期间,主体中的感兴趣的主平面保持基本上聚焦。 电子视频信号的一系列帧在不同的旋转位置处从检测器导出,这些帧代表身体在一系列连续时间的辐射传播特性的图像。 一系列帧被时间过滤,然后显示。 在优选实施例中,时间滤波步骤包括用具有时间频率响应的滤波器函数对视频信号的一系列帧进行滤波,该时间频率响应基本上对应于通过所成像的区域的大量对比材料的运动的时间频率。
    • 38. 发明申请
    • Self Cleaning Catheter and Methods of Use Thereof
    • 自清洁导管及其使用方法
    • US20100106236A1
    • 2010-04-29
    • US12373854
    • 2007-07-13
    • James A. Nelson
    • James A. Nelson
    • A61M25/00A61M16/04A61F2/84
    • A61M25/00
    • An improved catheter is provided for insertion into a trachea, blood vessel, bladder or urinary tract of a patient. The self cleaning catheter can be easily inserted and removed from the patient without retained, solid components falling into a patient's trachea, blood vessels, bladder, or urinary tract when the catheter is removed from the patient. The self cleaning catheter has a flexible cylindrical sleeve on the exterior of a cylindrical member that can be withdrawn to the interior of the catheter prior to removal from the patient's body. Alternatively, the catheter has a design allowing an end of the catheter to fold inward on itself prior to removal from the patient's body.
    • 提供改进的导管用于插入患者的气管,血管,膀胱或泌尿道。 当导管从患者身上取出时,自清洁导管可以容易地从患者插入和取出,而没有保留的固体组分落入病人的气管,血管,膀胱或尿道。 自清洁导管在圆柱形构件的外部具有柔性圆柱形套筒,其可以在从患者身体移除之前被抽出到导管内部。 或者,导管具有允许导管的端部在从患者身体移除之前向内折叠的设计。
    • 39. 发明授权
    • Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
    • 环戊基[b] [1,4]二氮杂[6,7,1-hi]吲哚及其衍生物
    • US07271163B2
    • 2007-09-18
    • US10898029
    • 2004-07-23
    • Annmarie L. SabbRobert L. VogelJames A. NelsonSharon J. Rosenzweig-LipsonGregory S. WelmakerJoan E. Sabalski
    • Annmarie L. SabbRobert L. VogelJames A. NelsonSharon J. Rosenzweig-LipsonGregory S. WelmakerJoan E. Sabalski
    • A61K31/55A61P25/00A61P25/24C07D243/00
    • C07D209/94A61K31/55C07D487/06
    • This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R3 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl, alkoxy of 1-6 carbon atoms, —CH2OH, fluoroalkyl, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, aryl, or aroyl; R4 and R5 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, fluoroalkyl, —CN, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R6 and R7 are each independently hydrogen, C1-C6 alkyl or cycloalkyl; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions containing these compounds and methods for their use, including treatment of obsessive-compulsive disorder, panic disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
    • 本发明提供下式的化合物:其中:R 1是氢,-C(O)CH 3或1-6个碳原子的烷基; R 2和R 3各自独立地为氢,1-6个碳原子的烷基,环烷基,1-6个碳原子的烷氧基,-CH 2 1-6个碳原子的烷基磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基,1个碳原子的氟代烷氧基 -6个碳原子,2-7个碳原子的酰基,芳基或芳酰基; R 4和R 5各自独立地为氢,1-6个碳原子的烷基,1-6个碳原子的烷氧基,卤素,氟烷基,-CN,烷基 1-6个碳原子的磺酰胺,1-6个碳原子的烷基酰胺,1-6个碳原子的烷基氨基,每个烷基部分1-6个碳原子的二烷基氨基,1-6个碳原子的氟烷氧基,2- 7个碳原子或芳酰基; R 6和R 7各自独立地为氢,C 1 -C 6烷基或环烷基; 或其药学上可接受的盐,以及含有这些化合物的药物组合物及其使用方法,包括治疗强迫症,恐慌症,抑郁症,焦虑症,广泛性焦虑症,精神分裂症,偏头痛,睡眠障碍,进食障碍, 肥胖,癫痫和脊髓损伤。